Moreover, Arakaki’s work showed that macrophage depletion from RCC xenografts overexpressing MCP-1 markedly suppressed tumor growth and angiogenesis, suggesting that MCP-1 inhibition exhibits anti-tumor effects against RCCs, at least partially, through the reduction of macrophage recruitment into the tumor [10]. This evidence concerns the gene CCL2 and neoplasm.